signature=f277c8765a4d38bfd168585b760ffe5f,CXCL13/CXCR5 enhances sodium channel Nav1.8 current densi...

Charo, I. F. & Ransohoff, R. M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354, 610–621 (2006).

Asensio, V. C. & Campbell, I. L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22, 504–512 (1999).

Savarin-Vuaillat, C. & Ransohoff, R. M. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 4, 590–601 (2007).

Cao, D. L. et al. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2. Exp Neurol 261C, 328–336 (2014).

Gao, Y. J. et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29, 4096–4108 (2009).

Verge, G. M. et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20, 1150–1160 (2004).

Zhang, Z. J., Cao, D. L., Zhang, X., Ji, R. R. & Gao, Y. J. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 154, 2185–2197 (2013).

Jiang, B. C. et al. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest 126, 745–761 (2016).

Cartier, L., Hartley, O., Dubois-Dauphin, M. & Krause, K. H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48, 16–42 (2005).

Scholz, J. & Woolf, C. J. Can we conquer pain? Nat Neurosci 5 Suppl, 1062–1067 (2002).

Weng, X., Smith, T., Sathish, J. & Djouhri, L. Chronic inflammatory pain is associated with increased excitability and hyperpolarization-activated current (Ih) in C- but not Adelta-nociceptors. Pain 153, 900–914 (2012).

Grace, P. M., Hutchinson, M. R., Maier, S. F. & Watkins, L. R. Pathological pain and the neuroimmune interface. Nat Rev Immunol 14, 217–231 (2014).

Yang, R. H., Strong, J. A. & Zhang, J. M. NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons. Mol Pain 5, 26 (2009).

Nemoto, W. et al. Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice. Mol Pain 9, 38 (2013).

Strong, J. A., Xie, W., Coyle, D. E. & Zhang, J. M. Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain. PLoS One 7, e40779 (2012).

Dib-Hajj, S. D., Cummins, T. R., Black, J. A. & Waxman, S. G. Sodium channels in normal and pathological pain. Annu Rev Neurosci 33, 325–347 (2010).

Amir, R. et al. The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain 7, S1–29 (2006).

Cummins, T. R., Sheets, P. L. & Waxman, S. G. The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain 131, 243–257 (2007).

Roza, C., Laird, J. M., Souslova, V., Wood, J. N. & Cervero, F. The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol 550, 921–926 (2003).

Obata, K. et al. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 23, 4117–4126 (2003).

Csati, A. et al. Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. J Headache Pain 16, 99 (2015).

Quintao, N. L., Medeiros, R., Santos, A. R., Campos, M. M. & Calixto, J. B. The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. Anesth Analg 101, 1763–1769 (2005).

Tamura, S., Morikawa, Y. & Senba, E. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor. Neuroscience 133, 797–806 (2005).

Liang, L., Fan, L., Tao, B., Yaster, M. & Tao, Y. X. Protein kinase B/Akt is required for complete Freund’s adjuvant-induced upregulation of Nav1.7 and Nav1.8 in primary sensory neurons. J Pain 14, 638–647 (2013).

Kiyomoto, M. et al. Fractalkine signaling in microglia contributes to ectopic orofacial pain following trapezius muscle inflammation. J Neurosci 33, 7667–7680 (2013).

Piao, Z. G. et al. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 121, 219–231 (2006).

Naor, Z., Benard, O. & Seger, R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11, 91–99 (2000).

Jarvis, M. F. et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 104, 8520–8525 (2007).

Moon, J. Y. et al. The differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesia. Anesth Analg 114, 215–223 (2012).

Joshi, S. K. et al. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models. J Pain 10, 306–315 (2009).

Ji, R. R., Gereau, R. W. t., Malcangio, M. & Strichartz, G. R. MAP kinase and pain. Brain Res Rev 60, 135–148 (2009).

Hudmon, A. et al. Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 28, 3190–3201 (2008).

Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309–314 (2000).

Forster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037–1047 (1996).

Ransohoff, R. M., Liu, L. & Cardona, A. E. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 82, 187–204 (2007).

Ramesh, G. et al. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation 6, 23 (2009).

Narayan, K. et al. The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis. Ann Neurol 57, 813–823 (2005).

Bagaeva, L. V., Rao, P., Powers, J. M. & Segal, B. M. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176, 7676–7685 (2006).

Magliozzi, R., Columba-Cabezas, S., Serafini, B. & Aloisi, F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148, 11–23 (2004).

Gao, Y. J. & Ji, R. R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 126, 56–68 (2010).

Zhuang, Z. Y. et al. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21, 642–651 (2007).

Oh, S. B. et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21, 5027–5035 (2001).

Coggeshall, R. E., Tate, S. & Carlton, S. M. Differential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed rats. Neurosci Lett 355, 45–48 (2004).

Zhang, Q., Cao, D. L., Zhang, Z. J., Jiang, B. C. & Gao, Y. J. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice. J Neuroinflammation 13, 183 (2016).

Joshi, S. K. et al. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain 123, 75–82 (2006).

Prochazkova, M. et al. Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia. Mol Pain 9, 66 (2013).

Gold, M. S., Levine, J. D. & Correa, A. M. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 18, 10345–10355 (1998).

Zhou, Z., Davar, G. & Strichartz, G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J Neurosci 22, 6325–6330 (2002).

Cardenas, L. M., Cardenas, C. G. & Scroggs, R. S. 5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels. J Neurophysiol 86, 241–248 (2001).

Takeda, M. et al. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn. Neuroscience 125, 995–1008 (2004).

England, S., Bevan, S. & Docherty, R. J. PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 495 (Pt 2), 429–440 (1996).

Zhao, R. et al. PKC-NF-kappaB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons. Biosci Rep 34 (2014).

Obata, K. & Noguchi, K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 74, 2643–2653 (2004).

Obata, K. et al. Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats. Eur J Neurosci 20, 2881–2895 (2004).

Ji, R. R., Samad, T. A., Jin, S. X., Schmoll, R. & Woolf, C. J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57–68 (2002).

Jin, S. X., Zhuang, Z. Y., Woolf, C. J. & Ji, R. R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23, 4017–4022 (2003).

Zhao, L. X., Jiang, B. C., Wu, X. B., Cao, D. L. & Gao, Y. J. Ligustilide attenuates inflammatory pain via inhibition of NFkappaB-mediated chemokines production in spinal astrocytes. Eur J Neurosci 39, 1391–1402 (2014).

Iwasaki, S. et al. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J Biol Chem 274, 26503–26510 (1999).

Hylden, J. L. & Wilcox, G. L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67, 313–316 (1980).

Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408 (2001).

Park, C. K. et al. Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 31, 15072–15085 (2011).

Lu, Y. et al. TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-alpha and IL-1beta signaling. Pain 155, 2618–2629 (2014).

Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53, 55–63 (1994).

Cha, M., Kohan, K. J., Zuo, X., Ling, J. X. & Gu, J. G. Assessment of chronic trigeminal neuropathic pain by the orofacial operant test in rats. Behav Brain Res 234, 82–90 (2012).

Miyoshi, K., Obata, K., Kondo, T., Okamura, H. & Noguchi, K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 28, 12775–12787 (2008).